A K2P3.1/TASK1 inhibitor
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

A-1899

Item No. 43018

Technical Information
Formal Name
N-[(2,4-difluorophenyl)methyl]-2′-[[[2-(4-methoxyphenyl)acetyl]amino]methyl]-[1,1′-biphenyl]-2-carboxamide
CAS Number
498577-46-1
Synonyms
  • S-20951
Molecular Formula
C30H26F2N2O3
Formula Weight
Purity
≥95%
A solid
DMSO: Soluble: ≥10 mg/ml
SMILES
O=C(NCC1=CC=C(C=C1F)F)C2=C(C=CC=C2)C3=C(CNC(CC4=CC=C(C=C4)OC)=O)C=CC=C3
InChi Code
InChI=1S/C30H26F2N2O3/c1-37-24-14-10-20(11-15-24)16-29(35)33-18-21-6-2-3-7-25(21)26-8-4-5-9-27(26)30(36)34-19-22-12-13-23(31)17-28(22)32/h2-15,17H,16,18-19H2,1H3,(H,33,35)(H,34,36)
InChi Key
IXKPEYHRIVQTCU-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    A-1899 is an inhibitor of the two-pore domain potassium channel 3.1 (K2P3.1/TASK1; IC50 = 0.035 µM in Xenopus oocytes expressing the human channel).1 It is selective for K2P3.1/TASK1 over K2P5.1/TASK2, K2P9.1/TASK3, and K2P17.1/TASK4 (IC50s = 12, 0.318, and 8.1 µM, respectively) and a panel of 16 additional potassium channels at 0.1 µM. A-1899 (3 mg/kg) selectively increases the effective refractory period (ERP) in the left atrium over the right atrium and does not affect ventricular repolarization in anesthetized pigs.2 It stimulates breathing and induces respiratory alkalosis in spontaneously breathing anesthetized rats when administered at a dose of 25 mg/kg.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Streit, A.K., Netter, M.F., Kempf, F., et al. A specific two-pore domain potassium channel blocker defines the structure of the TASK-1 open pore. The Journal of Biological Chemisty 286(16), 13977-13984 (2011).

    2. Knobloch, K., Brendel, J., Peukert, S., et al. Electrophysiological and antiarrhythmic effects of the novel IKur channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the IKr blockers dofetilide, azimilide, d,l-sotalol and ibutilide. Naunyn Schmiedebergs Arch Pharmacol. 366(5), 482-487 (2002).

    3. Cotten, J.F. TASK-1 (KCNK3) and TASK-3 (KCNK9) tandem pore potassium channel antagonists stimulate breathing in isoflurane-anesthetized rats. Anesth. Analg. 116(4), 810-816 (2013).